HONG KONG, Dec. 11, 2025 -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced the presentation of a Phase II clinical study that included a longer-term efficacy data evaluating ivonescimab (a PD-1/VEGF bispecific antibody) combined with chemotherapy as a first-line treatment for locally advanced unresectable or metastatic triple-negative breast cancer (TNBC) at the 2025 European Society for Medical Oncology Immuno-Oncology Congress (ESMO IO) in London, UK. Based on positive efficacy and safety profile, the ivonescimab combination therapy for first-line TNBC
Employee Celebrations Continue to Celebrate Eight Decades of Dedication and Innovation PORTLAND, Ore., Dec. 11, 2025 -- DSC®, a global leader in high-performance foam innovation, proudly culminates its 80th anniversary celebrating its employees around the globe through the end of the year. The anniversary marks eight decades of the people behind DSC®, advancing high-performance materials rooted in sustainability and innovation. Since 1945, DSC® employees have remained committed to developing foams and footwear components that reduce environmental impact across desi
TAIPEI, Dec. 11, 2025 -- The 2025 Taiwan International Student Design Competition (TISDC), organized by the Ministry of Education and executed by National Taiwan University of Science and Technology (NTUST), celebrated its award ceremony today. This year's competition received an impressive 16,329 submissions from 1,029 schools across 73 countries and regions, with 76 outstanding works selected as winners. Taiwanese students delivered exceptional results, earning the Grand Prix, the Gold Prizes in Visual Design and Fashion Design, and several other major honors, achieving a total of 43 awarde
Offline Awards Ceremony Unites Winners in Hong Kong—Showcasing Local Investor Enthusiasm and Futu's Commitment to Empowering Retail Investors HONG KONG, Dec. 11, 2025 -- The Second Futu Global Paper Trading Competition, hosted by Futu Group, recently concluded successfully. This year's competition attracted over 350,000 investors from eight major regions worldwide. In a stunning display of investment acumen, a participant from Hong Kong market claimed the championship title with an extraordinary total return rate of 7,528.1%—setting a standout benchmark for the competition. Sec
[ 메디채널 김장윤(JASON KIM) 기자 ] 우후, 중국 2025년 12월 11일 -- 급변하는 현대 도시에 사는 사람들은 점점 더 휴식과 정서적 균형 및 진정으로 자신만의 공간을 갈망한다. 체리 그룹(Chery Group)의 신에너지 브랜드 레파스(LEPAS)는 LEPAS L8의 '엑스퀴지트 스페이스(Exquisite Space)'를 이동형 정서적 안식처로 구현해, 모든 출발과 멈춤의 순간을 우아한 삶과 편안함이 깃든 시간으로 바꿔준다. 우아한 삶은 자신을 기쁘게 하는 소소한 즐거움에서 시작된다. LEPAS L8의 엑스퀴지트 스페이스 안에서 사용자는 곧바로 자신만의 행복한 정서적 안식처로 빠져들 수 있다. 앞좌석을 완전히 뒤로 젖히고 프로젝터 생태계 액세서리와 차량 내 엔터테인먼트 시스템을 연결하면 실내 공간은 개인용 이동식 영화관으로 변한다. 폭포형 중앙 디스플레이는 시각적 몰입도를 높이고, 극장급 정숙성을 갖춘 실내 공간은 외부 소음을 말끔히 차단한다. 자갈 모양의 프리미엄 스피커가 장착된 이 몰입형 공간은 우아한 드라이빙을 마음을 진정시키는 정서적 의식으로 승화시킨다. 주말여행이나 즉흥적인 캠핑을 떠날
HONG KONG, Dec. 11, 2025 -- Hakka medicine is the result of deep integration between traditional Central Plains Chinese medicine and the natural environment of southern China, carrying profound historical heritage and unique clinical value. The Seventh World Hakka Entrepreneurs Convention was held in Meizhou, Guangdong from November 23 to 25. With the theme of "Gather Global Hakka Entrepreneurs • Facilitate High-Quality Development", the conference upheld the principles of "openness, innovation, cooperation, and mutual benefit," and explored new opportunities for the deve
SEOUL, South Korea, Dec. 11, 2025 -- RIMAN, the premium K-beauty and wellness brand, is rapidly expanding its global footprint across North America, Asia, and Europe as it prepares for its official launch in Japan, one of the world's most sophisticated and influential beauty markets. RIMAN began its global expansion in 2022 with its entry into the United States and Canada, establishing a strong foundation in North America. Since then, the company has continued to grow across influential markets including Taiwan region, Hong Kong SAR, Malaysia, Singapore, the Philippines
광범위한 치료 잠재력을 가진 독자적 플랫폼 기술 '스타카토 원 브레스 테크놀로지' 인수 리스 팜의 기존 제품 파이프라인과 시너지 및 상호 보완 효과 UCB와의 글로벌 파트너십 하에 '스타카토 알프라졸람'의 라이선스 제공자 및 제조사 권리 획득 홍콩 2025년 12월 11일 -- 리스 파마슈티컬 홀딩스(Lee's Pharmaceutical Holdings Limited, 이하 "리스 팜")의 100% 자회사인 델라웨어 법인 노바 뉴마(Nova Pneuma Inc., 이하 "NPI")는 오늘 알렉자 파마슈티컬스(Alexza Pharmaceuticals, Inc., 이하 "알렉자")로부터의 자산 인수를 발표했다. 이번 거래로 리스 팜과 NPI는 지적재산권, 노하우, 상표, 제품 파이프라인, 장비, 제품 및 GMP(의약품 제조 및 품질 관리 기준) 시설 접근권을 포함한 '스타카토 원 브레스 테크놀로지(Staccato(R) One Breath Technology(R), 이하 "스타카토 OBT")' 플랫폼 및 자산에 대한 완전한 소유권을 확보하게 됐다.
Company receives the highest Water Security rating in two years into participation Recognized for exceptional leadership in environmental stewardship INCHEON, South Korea, Dec. 11, 2025 -- Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced that it has received from the Carbon Disclosure Project (CDP) an 'A' rating in Water Security. Two years into its participation in CDP assessments, Samsung Biologics has earned the top rating in Water Security, one rating higher than last year.
SYDNEY, Dec. 11, 2025 -- Razor Labs (TASE:RZR) announces the launch of DataMind AI™ 4.5, a powerful upgrade to its predictive maintenance platform designed for mobile fleet management and fixed assets across mining operations. Built through continuous collaboration with dozens of global mining sites, Version 4.5 delivers clearer diagnostics, faster insights, and stronger visibility for maintenance and reliability teams. "Version 4.5 was shaped together with dozens of mining sites operating a wide variety of mobile fleets and fixed assets," said Raz Roditti, CEO. "It deli